Although individual PD-L1 ligand expression status did not significantly influence disease-free survival (DFS) in GBM (data not shown), GBM patients with high PD-L2 expression showed a trend of shorter DFS than patients with low expression (Fig. 5A, left)(log rank test P = 0.0548). The gene discussed is CD274; the disease is glioblastoma.